Abbreviations:CI (confidence interval), MR (magnetic resonance), MRI (magnetic resonance imaging), SADE (serious adverse device effect), SAR (specific absorption rate)
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Current clinical issues for MRI scanning of pacemaker and defibrillator patients.Pacing Clin Electrophysiol. 2005; 28: 326-328
- Do we need MR conditional pacemakers?.Kardiovaskuläre Medizin. 2010; 13: 70-74
- Effect of magnetic resonance imaging on DDD pacemakers.Am J Cardiol. 1986; 57: 437-440
- The effects of nuclear magnetic resonance imagers on external and implantable pulse generators.Pacing Clin Electrophysiol. 1984; 7: 720-727
- The effects of nuclear magnetic resonance on patients with cardiac pacemakers.Radiology. 1983; 147: 149-153
- MR imaging and cardiac pacemakers: in-vitro evaluation and in-vivo studies in 51 patients at 0.5 T.Radiology. 2000; 215: 869-879
- Pacemaker safety during magnetic resonance imaging at 1.5 Tesla (abstract).J Am Coll Cardiol. 2001; 37: 436A
- Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance.Circulation. 2007; 116: 2878-2891
- Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association.Europace. 2007; 9: 959-998
- Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment.Heart Rhythm. 2011; 8: 65-73
- System Study Investigators. Randomized trial of pacemaker and lead system for safe scanning at 1.5 Tesla.Heart Rhythm. 2013; 10: 685-691
- System Study Investigators: impact of the Advisa MRI pacing system on the diagnostic quality of cardiac MR images and contraction patterns of cardiac muscle during scans: Advisa MRI randomized clinical multicenter study results.Heart Rhythm. 2013; 10: 864-872
- 2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.J Am Coll Cardiol. 2013; 61: e6-e75
Biotronik Cardiac Rhythm Management Product Performance Report, January 2014. Accessed June 4, 2014. Available at: http://www.biotronik.com/files/E3C148A8C88E9E4EC1257AEE004C5CF0/$FILE/product_performance_report_EN.pdf.
- Short- and long-term electrical performance of the 5086MRI pacing lead.Heart Rhythm. 2014; 11: 222-229
- Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla.Circulation. 2006; 114: 1277-1284
- Magnetic resonance imaging of pacemakers and implantable cardioverter-defibrillators without specific absorption rate restrictions.Europace. 2010; 12: 947-951
- The safety of MRI scanning of pacemakers and ICDs: what are the critical elements of safe scanning? Ask me again at 10,000.Europace. 2010; 12: 915-917
- The world survey of cardiac pacing and cardioverter-defibrillators: calendar year 2005 an International Cardiac Pacing and Electrophysiology Society (ICPES) project.Pacing Clin Electrophysiol. 2008; 31: 1202-1212
- Safe magnetic resonance imaging scanning of patients with cardiac rhythm devices: a role for computer modeling.Heart Rhythm. 2013; 10: 1815-1821
Dr. Bailey is a trial investigator and has received research support from Biotronik; has received speaking honoraria from Biotronik; and has served as a consultant for Biotronik. Dr. Rosenthal is a trial investigator and has received research support from Biotronik. Dr. Fananapazir is a trial investigator and has received research support from Biotronik. Dr. Gleva is a trial investigator and has received research support from Biotronik. Dr. Mazur is a trial investigator and has received research support from Biotronik. Dr. Rinaldi is a trial investigator and has received research support and honoraria from Biotronik. Dr. Kypta is a trial investigator and has received research support from Biotronik. Dr. Merkely is a trial investigator and has received research support from Biotronik. Dr. Woodard participated as a consultant to Biotronik for this trial. Biotronik Inc provided funding for the trial and is the manufacturer of the pacemaker systems used in the trial. ClinicalTrials.gov Identifiers: NCT01460992 and NCT01761162.